Policy & Compounding
Peptides Have Arrived: HHS Won't Pursue Pharmacies Making Six of Them
HHS filed a draft policy saying it won't pursue pharmacies compounding six peptides. What changed, what didn't, and how to stay safe.
Science & Research
The trials, pipelines and studies behind the headlines.
Policy & Compounding
The FDA Sent a Peptide Compounding Plan for Review: What Changes, and What Hasn't Yet
The White House logged an FDA peptide compounding policy on Oct 14. See what it could change, what's still not legal, and what to watch.
Science & Research
Stopping a GLP-1 Was Linked to Less Heart Protection in a Large Study of Veterans With Type 2 Diabetes
A study of over 333,000 veterans with diabetes linked stopping GLP-1s to fading heart benefit. See what it found and what it can't prove.
Policy & Compounding
Peptides Are Coming to Telehealth Checkouts. Here Is What to Look For.
Big telehealth brands plan to sell peptides. Learn which ones have a legal path, what the LegitScript seal checks, and the red flags.
Policy & Compounding
Lifestyle Habits Stacked Against Peptides: Which Makes You Live Longer
Most peptides in a wellness stack have zero human trials. See what the research shows, and the 12-year gap five basic habits produced.
Policy & Compounding
1 in 18 Black Market Peptide Vials Matched Its Label
An Australian lab tested 18 vials sold as retatrutide. One matched its label. See what the dosing errors were and why a purity test proves little.
More in Science & Research
- Science & Research
Walking Gets You Most of the Longevity Benefit, and Tops Out Sooner Than You Think
The longevity benefit of walking plateaus at 6,000 to 8,000 steps after 60. See what the research says and why strength gets mentioned on a GLP-1.
- Science & Research
Blocking GLP-1 for 16 Weeks Caused No Weight Regain for Those with Post-Bariatric Hypoglycemia
Avexitide blocks the GLP-1 receptor and cut severe blood sugar crashes 55%, with no weight change in either group. What that means if you take a GLP-1
- Policy & Compounding
People Are Injecting 'Barbie Peptides' to Tan. Here's What the FDA Actually Says About Melanotan
Melanotan II is sold as a tanning shortcut. See the FDA's own safety language, the published case reports, and where the 2026 peptide review stands.
- Science & Research
The FDA Wants to Limit Where Compounded GLP-1s Come From
The FDA proposed limiting large-scale compounded GLP-1s. See what is actually being decided and which pathway stays open.
- Policy & Compounding
FDA Panel Backs 6 Peptides for Compounding: What's Next
An FDA panel backed 6 of 7 peptides for the compounding list. See the votes, what each was proposed to treat, and what has to happen next.
- Lifestyle & Nutrition
PCOS Is Now PMOS: What the Name Change Means for You
PCOS has been renamed PMOS. See what the new name means, why it changed, and what the research shows about GLP-1s for this common condition.
